13D Filing: Sarissa Capital Management and Novelion Therapeutics Inc. (NVLN)

Page 3 of 3

Page 3 of 3 – SEC Filing

SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.
Dated:  August 4, 2017

SARISSA CAPITAL MANAGEMENT LP
By:
/s/ Mark DiPaolo                              
Name: Mark DiPaolo
Title: General Counsel
SARISSA CAPITAL DOMESTIC FUND LP
By: Sarissa Capital Fund GP LP, its general partner
By:
/s/ Mark DiPaolo                              
Name: Mark DiPaolo
Title: Authorized Person
SARISSA CAPITAL OFFSHORE MASTER FUND LP
By: Sarissa Capital Offshore Fund GP LLC, its general partner
By:
/s/ Mark DiPaolo                              
Name: Mark DiPaolo
Title: Authorized Person
/s/Alexander J. Denner                                 
Alexander J. Denner

Follow Novelion Therapeutics Inc. (NASDAQ:NVLN)

Page 3 of 3